Physician profile
Daniel Hanon
NPI 1356458970
$3,059.64
in general payments reported to CMS, 2019-2025
14 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $41.30 · 2021: $2,211 · 2022: $43.23 · 2023: $83.49 · 2024: $323 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,127.72 | 2021 | |
| Treace Medical Concepts, INC. | $861.60 | 2021 | |
| Convatec INC. | $406.54 | 2023-2024 | |
| Stryker Corporation | $296.28 | 2019-2021 | |
| Abbott Laboratories | $117.60 | 2019-2025 | Esprit |
| Smith+Nephew, INC. | $101.21 | 2019-2025 | Q-Fix |
| Acera Surgical, INC. | $29.13 | 2022 | |
| Zimmer Biomet Holdings, INC. | $23.70 | 2020 | |
| Organogenesis INC. | $23.45 | 2019-2022 | |
| Globus Medical, INC. | $21.30 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $13.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $13.56 | 2025 | |
| Kci USA, INC. | $12.35 | 2021 | |
| Merck Sharp & Dohme LLC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hanon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.